Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Syöpäpotilaan Ennusteen Parantaminen Muuttamalla syövän mikroympäristöä ja Metaboliaa Liikunnalla ja lääkkeellisesti - Measuring Oncological Value of Exercise and Statin

NCT05796973 is registered in ClinicalTrials.gov with Tampere University Hospital as lead sponsor.

NCT NCT05796973
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05796973 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Syöpäpotilaan Ennusteen Parantaminen Muuttamalla syövän mikroympäristöä ja Metaboliaa Liikunnalla ja lääkkeellisesti - Measuring Oncological Value of Exercise and Statin
Lead sponsor
Tampere University Hospital
Phase
Phase 3
Overall status
Recruiting
Start date
March 31, 2023
Completion date
December 31, 2027
Enrollment
240 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, kidney cancer, metastatic breast cancer, metastatic kidney cancer, metastatic ovarian cancer, metastatic ovary cancer, metastatic prostate adenocarcinoma, metastatic prostate cancer, metastatic renal cancer, metastatic renal cell carcinoma, ovarian cancer, prostate cancer